Phase 2 Oedema Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Hereditary Angioedema (HAE)AngioedemaBradykinin-mediated Angioedema+1 more
Institute for Asthma and Allergy10 enrolled1 locationNCT07046806
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）
Diabetic Macular Oedema
Innovent Biologics Technology Limited (Shanghai R&D Center)150 enrolled1 locationNCT06908876
Active
Phase 2
Lymph node grafting for breast cancer related lymphoedema
Lymphoedema
Mr Winston McEwan64 enrolled1 locationACTRN12617000951358
Terminated
Phase 2
Open label trial of intramuscular pentosan polysulfate on acute traumatic knee injury
Bone marrow oedema lesion associated with acute traumatic knee injury
Paradigm BioPharmaceuticals Ltd40 enrolled1 locationACTRN12616000009415
Terminated
Phase 2
A Phase II randomised placebo-controlled, double blind, multisite study of Acetazolamide versus placebo for management of cerebral oedema in recurrent and/or progressive High Grade Glioma requiring treatment with Dexamethasone – The ACED trial
Cerebral Oedema in recurrent, progressive and/or persistent High Grade Glioma
The University of Sydney84 enrolled11 locationsACTRN12615001072505
Recruiting
Phase 2
Avastin versus Triamcinolone for Diabetic Macular Edema at the time of Cataract Surgery
CataractsDiabetic Macular Oedema
Royal Victorian Eye and Ear Hospital100 enrolled1 locationACTRN12611000888965
Recruiting
Phase 2
A phase II, 12 month, randomized, sham-controlled trial of ranibizumab (Lucentis) combined with grid laser compared with laser alone for the treatment of recalcitrant, diabetic macular oedema.
Diabetic RetinopathyDiabetic Macular Oedema
Novartis40 enrolled1 locationACTRN12611000063910
Completed
Phase 2
Efficacy and safety of Methotrexate injections into the eye for inflammatory diseases of the eye.
Visual loss due to macular oedema secondary to uveitis
Royal Victorian Eye and Ear Hospital10 enrolled1 locationACTRN12610001004055
Completed
Phase 2
The Efficacy and Safety of Treatment with Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
Macula oedema secondary to Branch Retinal Vein Occlusion.
Associate Professor Ian McAllister40 enrolled1 locationACTRN12607000262404
Completed
Phase 2Phase 3
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema (TDMX study)
Diabetic Macular Oedema
Professor Mark Gillies64 enrolled1 locationACTRN12605000244606
Completed
Phase 2Phase 3
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)
Diabetic Macular Oedema
Professor Mark Gillies70 enrolled1 locationACTRN12605000211662